Please wait
S-3333-279692N/APerspective Therapeutics, Inc.EX-FILING FEES0000728387424B5N/AN/A00007283872026-02-022026-02-02iso4217:USD

 

Exhibit 107

 

The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering. The maximum aggregate offering price of that offering is $500,000,000.